Literature DB >> 1329927

Oncogenic conversion alters the transcriptional properties of ets.

C Wasylyk1, B Wasylyk.   

Abstract

The vEts oncoprotein and its progenitor cEts1(p68) belong to a growing family of transcription factors that are related by the conserved ets domain. We show here that the ets domain and adjacent COOH-terminal amino acids are required for DNA binding by cEts1(p68). vEts differs from cEts1(p68) in both the COOH-terminal sequence and an amino acid substitution in the ets domain. The change in the COOH-terminal sequence markedly decreases its affinity for specific DNA, and the ets domain mutation further diminishes binding. vEts does not trans-activate through the ets (PEA3) motif in vivo. Surprisingly, vEts still efficiently trans-activates the promoters of two genes, stromelysin and collagenase, that are found to be overexpressed in transformed cells. The AP1 motifs of both promoters are required for efficient activation. vEts does not bind to the AP1 motif, even in the presence of cJun and cFos. The DNA-binding domain of Ets1 is required for activation through the AP1 element. Activation is inhibited by the expression of the glucocorticoid and retinoic acid receptors, suggesting that activation by Ets does not involve reversal of negative regulators of AP1. We suggest that activation is by an indirect mechanism involving activation of endogenous genes. Our results show that vEts differs from its progenitor cEts1(p68) in its trans-activating properties. The findings suggest that activation of the Jun and Fos oncoprotein pathway is important for transformation by Ets.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1329927

Source DB:  PubMed          Journal:  Cell Growth Differ        ISSN: 1044-9523


  6 in total

1.  Cathepsin B: Basis Sequence: Mouse.

Authors:  Dora Cavallo-Medved; Kamiar Moin; Bonnie Sloane
Journal:  AFCS Nat Mol Pages       Date:  2011-04-10

2.  Oncogenic conversion of Ets affects redox regulation in-vivo and in-vitro.

Authors:  C Wasylyk; B Wasylyk
Journal:  Nucleic Acids Res       Date:  1993-02-11       Impact factor: 16.971

3.  A residue of the ETS domain mutated in the v-ets oncogene is essential for the DNA-binding and transactivating properties of the ETS-1 and ETS-2 proteins.

Authors:  N Soudant; O Albagli; P Dhordain; A Flourens; D Stéhelin; D Leprince
Journal:  Nucleic Acids Res       Date:  1994-09-25       Impact factor: 16.971

4.  Identification of target genes for the Ewing's sarcoma EWS/FLI fusion protein by representational difference analysis.

Authors:  B S Braun; R Frieden; S L Lessnick; W A May; C T Denny
Journal:  Mol Cell Biol       Date:  1995-08       Impact factor: 4.272

5.  The induction of CCN2 by TGFbeta1 involves Ets-1.

Authors:  Jonathan P Van Beek; Laura Kennedy; Jason S Rockel; Suzanne M Bernier; Andrew Leask
Journal:  Arthritis Res Ther       Date:  2006-01-16       Impact factor: 5.156

6.  Open chromatin profiling identifies AP1 as a transcriptional regulator in oesophageal adenocarcinoma.

Authors:  Edward Britton; Connor Rogerson; Shaveta Mehta; Yaoyong Li; Xiaodun Li; Rebecca C Fitzgerald; Yeng S Ang; Andrew D Sharrocks
Journal:  PLoS Genet       Date:  2017-08-31       Impact factor: 5.917

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.